All News
All news
-
News I Holland celebrates 70 years of tabletting excellence with technical seminars
The seminars discuss tablet design, tool material selection, tool features and configuration, tooling maintenance and lifecycle management. -
News Determining whether a powder will make a good tablet
Gamlen Tableting to demonstrate its new manufacturability protocol at AAPS. -
News Lonza and Clovis Oncology sign long-term manufacturing agreement to secure supply of rucaparib
First dedicated small-molecule manufacturing line to be constructed in Visp, Switzerland. -
News Sanofi Pasteur, Fiocruz, and WRAIR to collaborate on Zika vaccine research
The three research organizations have a history of flavivirus vaccine collaboration. -
News Is your innovation a potential winner?
Pharmapack Awards 2017 closing: Calling all pharma packaging and drug delivery innovators. -
News Skin patch to treat peanut allergy shows benefit in children
NIH-funded study suggests patch is safe, convenient mode of treatment. -
News Boehringer Ingelheim's adalimumab biosimilar candidate shows promise
Phase III study established equivalence in efficacy and similar safety profile between BI 695501 and Humira (adalimumab) in patients with active rheumatoid arthritis. -
News Bosch expands pharmaceutical portfolio
New solutions for the packaging process. -
News Teva and IBM expand global partnership to enable drug development and chronic disease management with Watson
Programs include a systematic approach to drug repurposing and data-driven, proactive chronic disease management - both fueled by the IBM Watson Health Cloud. -
News Clobazam oral suspension approved in seven European countries
Provides pan-European availability of widely used and much needed oral liquid version clobazam tablets. -
News Amgen to invest in Israel-based eHealth Ventures
Investment reflects Amgen's commitment to serving patients by driving innovation and sustainable healthcare through technology discovery. -
News New results presented for Opdivo (nivolumab)
Results demonstrate encouraging response rate in an expanded population of heavily pre-treated classical Hodgkin lymphoma patients. -
News FDA approves Merck’s Keytruda in metastatic NSCLC
Approval is for first-line treatment of patients whose tumours have high PD-L1 expression with no EGFR or ALK genomic tumour aberrations. -
News Pharma prospers with CPHI Worldwide attracting a record 42,000 attendees, as new industry trends emerge
Executives emphasised the importance of being first to market, two distinct outsourcing strategies, with biopharm and HPAPIs segments reporting strong growth. -
News Fighting cancer with the power of immunity
New treatment elicits two-pronged immune response that destroys tumors in mice. -
News Catalent celebrates ground breaking for expanded biologics facility
Company to invest $34 million in facility extension to add a new 2 x 2,000 L single-use bioreactor system and laboratory space. -
News Depression drugs sales in the US will reach $4.6 billion by 2025
The US will not only remain the largest major market for MDD drugs, but will extend its lead over other countries, says GlobalData. -
News All solutions under one roof
Under ideal circumstances, any B2C industry, pharmaceutical or otherwise, wants all his packaging to be procured from one place. Sourcing the primary packaging viz. laminate tubes and the secondary packaging viz. cartons; can help in better color match... -
News FDA approves sNDA for Xtandi capsules in advanced prostate cancer
Data demonstrate improvement in radiographic progression-free survival in patients with metastatic castration-resistant prostate cancer who were treated with enzalutamide compared to patients who were treated with bicalutamide. -
News Merck trial studying Keytruda in advanced bladder cancer meets primary endpoint and stops early
Keytruda is the first immunotherapy to show improved overall survival compared with chemotherapy in urothelial cancer. -
News Pfizer announces US availability of biosimilar Inflectra
Inflectra will be the first biosimilar monoclonal antibody (mAb) to be available in the US. -
News 3D cell culture experts assemble for inaugural New Frontiers in 3D Conference
Keynote speaker says traditional monolayer cell culture models used to study tumour chemoresistance have proven to be woefully inadequate. -
News Positive results from two pivotal Phase 3 studies of Revefenacin for the treatment of COPD
Top-line results across more than 1,250 moderate to very severe COPD patients confirmed that both Phase III studies met their primary efficacy endpoint. -
News Hikma Ventures invests in Propeller Health for the enhancement of leading respiratory technology platform
Propeller Health has developed a digital platform that integrates information from multiple sources and uses machine intelligence to recommend an optimal path therapy for individuals who suffer from COPD, asthma and other respiratory diseases. -
News A silicone antifoam agent SILFAR® S 184
Get to know SILFAR® S 184 - a silicone antifoam agent developed specifically for the pharmaceutical sector. Typical applications for SILFAR® S 184 include antiflatulent, antacid and fermented preparations. visit www.wacker.com -
News SOTIO and NBE Therapeutics sign collaboration and license agreement for next-generation ADCs
Collaboration will focus on the discovery, non-clinical development and manufacturing of novel ADC products against undisclosed targets. -
News Industry expert Kunal Jaiswal to head strategic development for Catalent's clinical supply services business
Will lead the company’s ongoing efforts to anticipate and act upon industry trends and technologies that may affect study sponsors, clinical sites, and patients, and to inform the development and delivery of current and future clinical supply services. -
News New pharmaceutical company opens in Canada
Sterinova to specialise in developing and manufacturing sterile ready-to-use injectable products. -
News Oxford Genetics opens new facility to support R&D in cell and gene therapy
The new facilities includes dedicated cell development suites and new robotic platforms for process automation. -
News Horizon Discovery signs subscription-based licensing agreement for biomanufacturing cell lines
The subscription deal, which is valued at a minimum of £500,000, provides partner access to Horizon's engineered cell lines. -
News FDA approves Genentech’s cancer immunotherapy Tecentriq for people with a specific type of metastatic lung cancer
First and only anti-PDL1 cancer immunotherapy approved by the FDA for metastatic non-small cell lung cancer. -
News FDA awards 21 grants to stimulate product development for rare diseases
The new clinical trial research grants total more then $23 million over the next 4 years. -
News Colombian pharmaceutical market to see strong market growth, surpassing $7 billion by 2020
Substantial rise can be attributed to increased drug consumption, caused by a rising disease burden, and government initiatives in the public healthcare sector. -
News Catalent to provide fill & finish services for commercial supply of Samsung Bioepis' biosimilar therapy
Pre-filled syringes to be produced at Brussels, Belgium facility. -
News A new player in appetite control
Brain cells that provide structural support also influence feeding behavior, study shows. -
News Lilly partners with the National Cancer Institute to accelerate cancer research through new program under Cancer Moonshot initiative
New database provides access to oncology studies in an effort to speed medicines to patients. -
News Merck expands biotech production capacity in Spain
Extension of manufacturing plant will help meet worldwide demand for fertility and growth hormone disorder treatments. -
News Merck Research Laboratories facilities designated as “Milestones in Microbiology” sites
Facilities chosen for their contributions to anti-infectives and vaccines. -
News Recipharm to open new GLP bioanalysis laboratory in Sweden
Will become the largest GLP bioanalysis laboratory of its kind in the Nordic countries. -
News Juniper Pharma Services expands granulation capabilities
The addition of a roller compactor support's the company's recent capability extensions made in spray drying, Xcelodose technology, bi-layer tablets production and high-speed encapsulation. -
News Cambrex wins API Development Award at CPHI Worldwide
Prize awarded for development of novel synthesis of Dronedarone intermediate. -
News Pharmapack Europe: 2017 marks 20 years of the pharma packaging and drug delivery event
The newest addition for 2017, the Pharmapack Start-up Hub, is designed to let innovative young pharma firms benefit from valuable networking and learning opportunities. -
News Boost your knowledge of applications and techniques in nanoscale characterisation
Postnova Analytics to host free 1-day seminar on advanced separation techniques. -
News I Holland to host troubleshooting in tablet tooling seminar
Will include sharing information on industry trends and tooling expertise. -
News CHMP adopts positive opinion of metformin
Includes Merck’s type 2 diabetes treatment portfolio, in patients with renal impairment. -
News Pfizer to present new data on Xeljanz for ulcerative colitis at UEG Week 2016
Includes an oral presentation looking at the effect of prior treatment with tumour necrosis factor inhibitors on efficacy endpoints. -
News Pall launches Kleenpak Presto sterile connectors for genderless fluid transfer applications
Can be used in a wide range of applications in upstream, downstream, and formulation and filling. -
News Allergan's Belkyra receives marketing authorisation in Sweden
Marketing authorization given for the treatment of moderate to severe fullness under the chin. -
News FDA grants Orphan Drug Designation for True North Therapeutics' lead product candidate, TNT009
TNT009 is currently in clinical development for the treatment of autoimmune hemolytic anemia, including Cold Agglutinin Disease (CAD), a form of autoimmune hemolytic anemia. -
News Cerbios-Pharma and Oncotec Pharma join PROVEO collaboration for manufacture of ADCs
Cerbios will provide highly cytotoxic drug payloads and conjugation services for manufacture of ADC drug substance whereas Oncotec will provide sterile filling and lyophilization of cytotoxic active ingredients for ADCs. -
News Study finds Ebola treatment ZMapp holds promise, although results not definitive
Trial shows rigorous clinical research feasible during a public health emergency. -
News Aptuit expands capabilities and capacity in formulation development and safety assessment
Company's continued expansion allows it to further improve the transition of drug candidates from the discovery medicinal chemistry space through to formal regulatory based drug product development. -
News PhoreMost and Cambridge Uni collaborate to identify innovative drug targets for neurodegenerative disease
The studies have the potential to reveal novel insights for previously unknown autophagy signalling components, which could suggest rapid and innovative starting points for new drug treatments. -
News Medivir focuses exclusively on oncology and reorganizes to significantly reduce the cost structure
Approximately 30 members of staff will lose their job. -
News Major depressive disorder market will reach $5.8 billion by 2025 as awareness and drugs improve
This substantial growth will primarily be driven by the growth of atypical antipsychotics, along with the increasing global diagnosed prevalence of MDD, and the potential introduction of six late-stage pipeline products. -
News NEUWAY Pharma and Cobra Biologics collaborate to develop GMP-grade engineered protein capsules manufacturing process
Collaboration supports GLP toxicity studies and initiation of clinical development for treatment of Progressive Multifocal Leukoencephalopathy. -
News Arch Biopartners receives patent for Metablok
Is the first patent issued protecting the composition and method of use for Metablok, the company's drug candidate targeting inflammation, sepsis and cancer metastasis. -
News FDA accepts sNDA for Avycaz
Application seeks to expand Avycaz label to include Phase III clinical data for the treatment of complicated urinary tract infections. -
News FDA approvs infant-specific dose of Pertzye delayed-release capsules to treat EPI due to cystic fibrosis
The new formulation will be offered in 4,000 lipase units capsule. -
News Merck announces recipients of third annual €1 million ‘Grant for Oncology Innovation’ award
Grant established by Merck recognizes pioneering research in personalized treatment of solid tumours. -
News Rapid and durable response in bladder cancer observed with nivolumab
Data were presented at the 2016 European Society for Medical Oncology Congress. -
News UAE pharmaceutical market set to hit $5.7 billion by 2020 as medical tourism grows
The UAE is quickly gaining popularity as a medical tourism destination due to its low costs, English-speaking medical staff, and virtually non-existent queues for treatment. -
News Mylan agrees to settlement on Medicaid Rebate Classification for EpiPen Auto-Injector
The terms of the settlement do not provide for any finding of wrongdoing on the part of Mylan Inc. or any of its affiliated entities or personnel. -
News Enterprise Therapeutics secures £4M funding to advance therapies for patients with respiratory disease
Funding will allow the company to advance its research projects and move closer towards its goal of evaluating the efficacy of muco-regulatory drugs in patients. -
News The first nutritional supplement against TB launches in Asia and Africa
Nyaditum resae targets to reduce the risk of developing the disease in people who carry the tuberculosis bacteria and those at risk of infection. -
News Orchard Therapeutics opens US operations in Foster City, California
Will provide the central technical base for laboratory operations associated with the development and validation of manufacturing processes and analytical methods for the company’s products. -
News BARDA awards $37.6 million contract to Sanofi to supply Leukine for potential public health emergency
Sanofi Genzyme expects to submit a supplemental Biologics License Application to the FDA next year. -
News Colorcon strengthens its global production capacity with a new Latin American manufacturing facility
Company to start manufacturing in Brazil. -
News Pall Life Sciences wins BPI 2016 Best Downstream Application Award
Cadence Acoustic Separator system is a novel single-use solution for the clarification of cell culture bioprocess fluids. -
News Gastrointestinal drugs market to hit $48.4 billion by 2022 as biologic products revolutionize the treatment space
Although the market has recently been hit by the patent expirations of a number of the leading gastrointestinal products, the approval of new drugs, as well as rising prevalence, are expected to drive considerable growth. says GBI Research. -
News Lilly subsidiary to acquire Boehringer Ingelheim Vetmedica's US feline, canine and rabies vaccines portfolio
Eight new product lines and a fully integrated manufacturing and R&D site to transfer to Elanco, adding to its growing companion animal business. -
News Intas Pharmaceuticals acquires Actavis UK & Ireland generics businesses from Teva
Transaction is part of the European Commission’s anti-trust divestiture requirements arising from Teva’s acquisition of Allergan’s generics business. -
News Patent trial and appeal board upholds the validity of Lialda patent
Shire pleased with the decision and will continue to vigorously defend its patents. -
News Pall Life Sciences launches the Cadence BioSMB Process system
Enables fully scalable, continuous multicolumn chromatography -
News How choice of reactor vessel affects reaction performance
New report compares the thermal performance and advantages of vacuum jacketed versus non-vacuum jacketed reaction vessels. -
News The winners of the 2016 CPHI Pharma Awards
13 prestigious pharma leaders picked from 100 entries. -
News Colorcon increases Suglets manufacturing capacity by 50%
Investments being made ahead of anticipated demand. -
News Capsugel expands capabilities for early-phase development through commercial manufacturing
Capabilities expanded across multiple locations in Europe. -
News CPHI Worldwide experts advocate single reference product for generics and printed personalised formulations
Big data forecast to revolutionise pharma’s operations, everything from outsourcing thorough to drug discovery. -
News US to lose dominance of global generics market as emerging economies take over
China and India tipped to become the highest revenue-generating emerging market for generic drug manufacturers in the next 5 years. -
News Merck launches two innovative technologies to support couples on their fertility treatment journey
Gavi allows freezing of oocytes and embryos at key stages, whereas Geri medium supports undisturbed embryo growth. -
News Colorcon shows new 'work anywhere' tablet coating at CPHI
Opadry QX is a new tablet film coating, designed to meet the manufacturing flexibility, batch consistency and efficiencies. -
News CPHI Worldwide experts predict CDMO mega-mergers and Chinese patented products imminent
HPAPI growth driven by virtual and mid-sized pharma, with biosimilars expanding rapidly in Europe. -
News Pharmaffiliates is now US-FDA accredited facility
We are pleased to announce that Our facility of (Haryana) India, was inspected by US-FDA and is successfully approved. -
News Sterling Pharma Solutions launches following management buyout
The CDMO will specialise in delivering API development and manufacturing solutions. -
News Recipharm launches serialisation showcase line
As part of the serialisation roll-out, the CDMO has developed a unique pricing model which spreads the cost of the process across each customer’s ongoing supply agreement, removing the need to make any upfront investment. -
News SGS invests in new cGMP Berlin, Germany facility
Company to expand its activities in R&D/QC testing, and to offer new analytical services to clients. -
News Cambrex opens new pilot plant at its Milan, Italy site
Adds speed and flexibility for small-scale API production. -
News Allergan enters into licensing agreement with AstraZeneca to obtain worldwide rights to MEDI2070 inflammatory disorder development program
MEDI2070 is in development as a next-generation IL-23-only targeted therapy for Crohn's disease and ulcerative colitis. -
News Late-breaking data show Novartis' Cosentyx delivers high and long-lasting skin clearance over 4 years for psoriasis patients
Cosentyx significantly superior to Stelara in delivering long-lasting skin clearance in psoriasis over 52 weeks. -
News Researchers find a gap in the brain’s firewall against Parkinson’s disease
NIH-funded mouse study identifies a key player in the progression of the disorder. -
News SSB launches two single-use Sartocon loop assemblies with integrated polyethersulfone membrane
Assemblies save up to 60% on processing time and offer a safe approach to ultrafiltration of biologics and vaccines. -
News Zenith Technologies appoints MES lead
James O’Brien will lead the company's manufacturing execution system business to its next phase of growth. -
News Pall Life Sciences to introduce continuous bioprocessing with single-use technologies
Will enable manufacturers to reduce costs by eliminating cleaning and validation requirements, as well as hardware infrastructure. -
News Novo Nordisk to cut workforce by approximately 1000 employees
The reductions are expected to affect R&D units and headquarter staff functions. -
News AbbVie opens first phase of its global manufacturing facility in Singapore
New site expands the company's global operations for small molecule and biologics manufacturing, and marks the company's first manufacturing presence in Asia. -
News Boehringer Ingelheim boosts immune-oncology pipeline through collaboration with ViraTherapeutics
New long-term collaboration to develop next generation oncolytic virus platform and lead candidate VSV-GP. -
News Eppendorf to showcase solutions to common lab challenges at Lab Innovations 2016
The company will exhibit and demonstrate a range of instruments and consumables from the liquid handling portfolio, including: pipettes & tips, manual and electronic dispensers and automated pipetting systems. -
News HPAPIs and biologic manufacturing present strong growth opportunities for CMOs
Providing value added development services will allow participants to edge out competition, finds Frost & Sullivan's Transformational Health team. -
News Malaysian pharmaceutical market forecast to see impressive growth, hitting $3.6 billion by 2020
Main drivers of this substantial growth include medical tourism, a lack of strict price regulation, a rising disease burden, and a lack of dependence on imported branded products. -
News Theratechnologies to move forward with development of new single vial formulation for Egrifta
The introduction of a single vial presentation was part of commitments required by the FDA when it approved Egrifta (Tesamorelin for Injection). -
News Bosch Packaging Technology presents HMI 4.0
The HMI 4.0 is suited for both stand-alone machines and entire lines and provides an interface for data collection, data sharing and visualization -
News Biogen completes rolling submission of NDA to FDA for nusinersen as a treatment for spinal muscular atrophy
Submission of Marketing Authorization Application to the EMA planned in the coming weeks. -
News SP Scientific purchases ControLyo nucleation technology
The technology controls the freezing stage of the freeze drying process for more consistent and repeatable outcomes that aid drug development, scale-up and production efforts. -
News Drug formulation specialist MedPharm opens US facility in Research Park Triangle
The new laboratories will enable pharmaceutical companies to test various topical and transdermal formulations for both new and existing drugs. -
News Merck launches Viresolve Pro Shield H for more robust, economical parvovirus removal
Removes protein aggregates and other impurities in high pH and high conductivity mAb feed streams. -
News CPHI Worldwide experts propose new FDA quality metrics system and recommend critical formulation attributes
Continuous processing at a ‘tipping point’, with CDMO implementation over next 3 years, but the industry needs a better definition of what ‘continuous’ means. -
News Cambrex to enhance its portfolio of small molecule API services
Acquisition of PharmaCore’s portfolio also complements Cambrex's existing large-scale, multi-purpose manufacturing facilities in the US and Europe. -
News Pfizer decides to remain as one company
Company to continue to operate as one company with two distinct and complementary businesses to retain operating strength and financial flexibility. -
News BARDA Grants $43.2 million USD to Sanofi Pasteur for Zika
Funds will be used for Phase II development and manufacturing. -
News Merck to showcase innovative excipients and Emprove Program at CPHI Worldwide
Innovative excipients for controlled release including, new biodegradable, biocompatible polymers for sustained release injectables and Parteck SRP 80 for oral solid formulation. -
News FDA approves Amgen's new biosimilar for multiple inflammatory diseases
Amjevita is the first adalimumab biosimilar approved by the FDA and has been approved for the treatment of seven inflammatory diseases. -
News Leading pharmaceutical companies present industry roadmap to combat antimicrobial resistance
Comprehensive roadmap lays out key commitments the pharmaceutical companies pledge to deliver by 2020 to reduce antimicrobial resistance. -
News Saneca Pharma strengthens senior team
Jeremy Drummond will focus on growing the CDMO’s API and finished dosage form development and manufacturing business in Europe and North America. -
News Novartis receives three new FDA approvals for the expanded use of Ilaris
Ilaris is the first and only US FDA-approved biologic treatment for patients with TRAPS, HIDS/MKD and FMF disease. -
News Dow and Colorcon extend and broaden the scope of the Controlled Release Alliance
Alliance will be extended to include Dow’s advanced technology-based pharmaceutical excipients. -
News Newcomer Kolb @ CPHI – Polysorbates, the unique Kolb product philosophy
50 years’ experience in manufacturing Polysorbates, Sorbitan Esters, and other non-ionic surfactants allows Kolb to steer this complex molecular diversity. Let’s talk about our new Hedisan product portfolio and its unique philosophy at CPHI Worldwide 2...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance